Immune cells use previously unknown pathway to eliminate acute myeloid leukemia. Researchers at The University of Texas MD Anderson Cancer Center have discovered a new way in which T cells attack acute myeloid leukemia (AML) cells, which may help explain why AML is particularly sensitive to immune-based treatments and could guide the development of future cancer immunotherapies.
A apuração publicada por medicalxpress.com vira base para uma leitura editorial direta e contextualizada.
Trechos de apoio da pauta: Researchers at The University of Texas MD Anderson Cancer Center have discovered a new way in which T cells attack acute myeloid leukemia (AML) cells, which may help explain why AML is particularly sensitive to immune-based treatments and could guide the development of future cancer immunotherapies.
- Ponto de atenção: immune.
- Ponto de atenção: cells.
- Ponto de atenção: previously.
Em resumo, a leitura editorial acompanha o impacto do tema no nicho Fitness.
:quality(85)/47eeaeec-3bbf-461d-9609-4b5ea6c45cdd.png)
